Healthcare Holding B.V. Gilde Sells 681 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 681 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $22.62, for a total transaction of $15,404.22. Following the sale, the insider owned 2,187,110 shares of the company’s stock, valued at approximately $49,472,428.20. This represents a 0.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.61, for a total value of $463,866.76.
• On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total value of $88,140.00.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.64, for a total value of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.77, for a total value of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.71, for a total value of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.73, for a total value of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Stock Down 0.0%

Shares of NYSE SI opened at $22.21 on Wednesday. The firm has a fifty day simple moving average of $21.10 and a two-hundred day simple moving average of $16.66. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $24.59. The company has a current ratio of 10.71, a quick ratio of 8.92 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $462.41 million and a PE ratio of -11.57.

Shoulder Innovations (NYSE:SI) last announced its earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). Shoulder Innovations had a negative net margin of 58.33% and a negative return on equity of 23.61%. The company had revenue of $17.18 million for the quarter. Equities analysts expect that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have weighed in on SI. Piper Sandler reiterated an “overweight” rating and set a $25.00 target price (up from $19.00) on shares of Shoulder Innovations in a report on Friday, August 7th. BTIG Research lifted their price target on Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, August 7th. UBS Group upped their price target on Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Finally, Weiss Ratings raised Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 3rd. Five research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, Shoulder Innovations has an average rating of “Moderate Buy” and a consensus price target of $25.50.

Institutional Trading of Shoulder Innovations

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Deerfield Management Company L.P. purchased a new position in Shoulder Innovations during the third quarter valued at $6,056,000. Alyeska Investment Group L.P. purchased a new stake in shares of Shoulder Innovations in the third quarter worth $5,667,000. Vanguard Group Inc. purchased a new stake in shares of Shoulder Innovations in the third quarter worth $1,836,000. Roubaix Capital LLC increased its holdings in shares of Shoulder Innovations by 61.9% during the first quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock valued at $3,736,000 after acquiring an additional 98,305 shares in the last quarter. Finally, Millennium Management LLC purchased a new position in shares of Shoulder Innovations in the 4th quarter worth about $1,316,000.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.